{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T12:28:18Z","timestamp":1786796898943,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.radonc.2026.111648","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T22:07:04Z","timestamp":1782079624000},"page":"111648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patient-reported quality of life after chemoradiotherapy in patients with non-metastatic anal squamous cell carcinoma: A cross-sectional cohort study"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8055-406X","authenticated-orcid":false,"given":"R.A.","family":"Lunenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.N.","family":"van Erning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8931-5301","authenticated-orcid":false,"given":"F.P.C.","family":"Sijtsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.H.J.T.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"van Triest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Grotenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-5517","authenticated-orcid":false,"given":"M.P.W.","family":"Intven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1398-8970","authenticated-orcid":false,"given":"J.M.L.","family":"Roodhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-7124","authenticated-orcid":false,"given":"J.J.M.","family":"Kwakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111648_b0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CEJ.0000000000000842","article-title":"Global trends in anal cancer incidence and mortality","volume":"33","author":"Mignozzi","year":"2024","journal-title":"Eur J Cancer Prev."},{"key":"10.1016\/j.radonc.2026.111648_b0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ijc.34269","article-title":"Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis","volume":"152","author":"Deshmukh","year":"2023","journal-title":"Int J Cancer."},{"key":"10.1016\/j.radonc.2026.111648_b0015","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ijc.34811","article-title":"Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990-2021)","volume":"154","author":"Ho","year":"2024","journal-title":"Int J Cancer."},{"key":"10.1016\/j.radonc.2026.111648_b0020","unstructured":"Netherlands Cancer Registry (NCR), Netherlands Comprehensive Cancer Organisation (IKNL), derived via www.iknl.nl\/en\/ncr\/ncr-data-figures."},{"key":"10.1016\/j.radonc.2026.111648_b0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/0003134820923326","article-title":"Association of Time Between Radiation and Salvage APR and Margin Status in Patients With Anal Cancer Treated With Concurrent Chemoradiation","volume":"86","author":"Lee","year":"2020","journal-title":"Am Surg."},{"key":"10.1016\/j.radonc.2026.111648_b0030","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/DCR.0000000000001630","article-title":"Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma: Use, Risk Factors, and Outcomes in a Canadian Population","volume":"63","author":"Patel","year":"2020","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.radonc.2026.111648_b0035","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s11605-023-05755-0","article-title":"Estimating Risk of Locoregional Failure and Overall Survival in Anal Cancer Following Chemoradiation: A Machine Learning Approach","volume":"27","author":"Chen","year":"2023","journal-title":"J Gastrointest Surg."},{"key":"10.1016\/j.radonc.2026.111648_b0040","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","article-title":"ESMO Guidelines Committee. Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Rao","year":"2021","journal-title":"Ann Oncol."},{"key":"10.1016\/j.radonc.2026.111648_b0045","first-page":"3613","article-title":"Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy","volume":"23","author":"Sodergren","year":"2015","journal-title":"Support Care Cancer."},{"key":"10.1016\/j.radonc.2026.111648_b0050","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00384-019-03342-x","article-title":"Quality of life in patients treated for anal carcinoma-a systematic literature review","volume":"34","author":"Sterner","year":"2019","journal-title":"Int J Colorectal Dis."},{"key":"10.1016\/j.radonc.2026.111648_b0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2022.05.009","article-title":"Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy","volume":"114","author":"De","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.radonc.2026.111648_b0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.radonc.2016.06.020","article-title":"Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer","volume":"120","author":"Joseph","year":"2016","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.radonc.2026.111648_b0065","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2340\/1651-226X.2025.43636","article-title":"Patient-reported outcomes after chemoradiotherapy for anal cancer","volume":"64","author":"Sl\u00f8rdahl","year":"2025","journal-title":"Acta Oncol."},{"issue":"12","key":"10.1016\/j.radonc.2026.111648_b0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2468-1253(18)30264-4","article-title":"A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus","volume":"3","author":"Fish","year":"2018","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.radonc.2026.111648_b0075","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1080\/0284186X.2016.1189094","article-title":"Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research","volume":"55","author":"Burbach","year":"2016","journal-title":"Acta Oncol."},{"key":"10.1016\/j.radonc.2026.111648_b0080","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ejca.2011.04.034","article-title":"The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts","volume":"47","author":"van de Poll-Franse","year":"2011","journal-title":"Eur J Cancer."},{"issue":"9","key":"10.1016\/j.radonc.2026.111648_b0085","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/bjc.2014.467","article-title":"Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option","volume":"111","author":"Meulendijks","year":"2014","journal-title":"Br J Cancer."},{"key":"10.1016\/j.radonc.2026.111648_b0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.radonc.2026.111648_b0095","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s11136-015-1210-5","article-title":"The EORTC QLQ-CR29 quality of life questionnaire for colorectal cancer: validation of the Dutch version","volume":"25","author":"Stiggelbout","year":"2016","journal-title":"Qual Life Res."},{"key":"10.1016\/j.radonc.2026.111648_b0100","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/codi.14228","article-title":"Dutch validation of the low anterior resection syndrome score","volume":"20","author":"Hupkens","year":"2018","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.radonc.2026.111648_b0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10350-005-0275-6","article-title":"A stoma quality of life scale","volume":"49","author":"Baxter","year":"2006","journal-title":"Dis Colon Rectum."},{"key":"10.1016\/j.radonc.2026.111648_b0110","unstructured":"Fayers PMAN, Bjordal K, Gr\u00f8nvold M, Curran D, Bottomley A. The EORTC QLQ-C30 Scoring Manual (3rd Edition). European Organisation for Research and Treatment of Cancer. 2001."},{"key":"10.1016\/j.radonc.2026.111648_b0115","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e31824f1c21","article-title":"Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer","volume":"255","author":"Emmertsen","year":"2012","journal-title":"Ann Surg."},{"key":"10.1016\/j.radonc.2026.111648_b0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.radonc.2026.111648_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.10.003","article-title":"Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research","volume":"118","author":"Giesinger","year":"2020","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.radonc.2026.111648_b0130","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ijrobp.2022.09.071","article-title":"One-Year Treatment-Related Side Effects and Quality of Life After Chemoradiotherapy in Squamous Cell Carcinoma of the Anus","volume":"115","author":"Lefevre","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.radonc.2026.111648_b0135","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/0284186X.2013.770599","article-title":"Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors","volume":"52","author":"Bentzen","year":"2013","journal-title":"Acta Oncol."},{"key":"10.1016\/j.radonc.2026.111648_b0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00066-010-2175-5","article-title":"Quality of life outcomes in patients with anal cancer after combined radiochemotherapy","volume":"187","author":"Welzel","year":"2011","journal-title":"Strahlenther Onkol."},{"key":"10.1016\/j.radonc.2026.111648_b0145","doi-asserted-by":"crossref","first-page":"O230","DOI":"10.1111\/codi.13076","article-title":"Long-term anorectal, urinary and sexual dysfunction causing distress after radiotherapy for anal cancer: a Danish multicentre cross-sectional questionnaire study","volume":"17","author":"Sunesen","year":"2015","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.radonc.2026.111648_b0150","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00066-013-0314-5","article-title":"Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature","volume":"189","author":"Fakhrian","year":"2013","journal-title":"Strahlenther Onkol."},{"key":"10.1016\/j.radonc.2026.111648_b0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2019.12.022","article-title":"UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes","volume":"128","author":"Gilbert","year":"2020","journal-title":"Eur J Cancer."},{"issue":"8","key":"10.1016\/j.radonc.2026.111648_b0160","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/annonc\/mdu188","article-title":"Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Annals of oncology"},{"issue":"26","key":"10.1016\/j.radonc.2026.111648_b0165","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1200\/JCO.2011.36.1790","article-title":"Cause-specific colostomy rates after radiotherapy for anal cancer: a Danish multicentre cohort study","volume":"29","author":"Sunesen","year":"2011","journal-title":"Journal of clinical oncology."},{"key":"10.1016\/j.radonc.2026.111648_b0170","article-title":"Response shift in health-related quality of life measures in the presence of formative indicators","volume":"19(1):9","author":"Testa","year":"2021","journal-title":"Health Qual Life Outcomes."},{"key":"10.1016\/j.radonc.2026.111648_b0175","first-page":"e1908","article-title":"The Patient's perspective on radiation therapy for anal cancer: Evaluation of expectations and stigma","volume":"6","author":"Chaballout","year":"2023","journal-title":"Cancer Rep (Hoboken)."},{"key":"10.1016\/j.radonc.2026.111648_b0180","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3390\/curroncol30030246","article-title":"Anal Cancer: The Past, Present and Future","volume":"30","author":"Gondal","year":"2023","journal-title":"Curr Oncol."},{"key":"10.1016\/j.radonc.2026.111648_b0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1470-2045(25)00213-X","article-title":"Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial","volume":"26","author":"Gilbert","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2026.111648_b0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s41747-025-00559-0","article-title":"Radiomics to predict tumor response to combination chemoradiotherapy in squamous cell carcinoma of the anal canal: a preliminary investigation","volume":"9","author":"Vanzulli","year":"2025","journal-title":"Eur Radiol Exp."},{"key":"10.1016\/j.radonc.2026.111648_b0195","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1038\/s41598-020-79890-y","article-title":"The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care","volume":"11","author":"Derksen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2026.111648_b0200","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.radonc.2017.11.018","article-title":"Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer","volume":"126","author":"Sodergren","year":"2018","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.radonc.2026.111648_b0205","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ijrobp.2022.11.002","article-title":"International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire","volume":"115","author":"Sodergren","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys."}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026004871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026004871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T12:17:19Z","timestamp":1786796239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026004871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"alternative-id":["S0167814026004871"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111648","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-reported quality of life after chemoradiotherapy in patients with non-metastatic anal squamous cell carcinoma: A cross-sectional cohort study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111648"}}